Literature DB >> 20529041

Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.

T Stewart1, N Pavlakis, M Ward.   

Abstract

In this case series we present a variety of different cardiac toxicities with 5-fluorouracil and its pro-drug capecitabine, including myocardial infarction, cardiomyopathy, sinoatrial and atrioventricular node dysfunction, takotsubo cardiomyopathy and QT prolongation with torsade-de pointes ventricular tachycardia. We stress the fact that while vasospasm is a well-recognized side-effect of this class of chemotherapeutic agent, broader cardiotoxicity is commonly seen and an increased awareness of the range of toxicity is necessary if repeat toxicity is to be avoided.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529041     DOI: 10.1111/j.1445-5994.2009.02144.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  39 in total

Review 1.  Malignancies and outcome in Takotsubo syndrome: a meta-analysis study on cancer and stress cardiomyopathy.

Authors:  Natale Daniele Brunetti; Nicola Tarantino; Francesca Guastafierro; Luisa De Gennaro; Michele Correale; Thomas Stiermaier; Christian Möller; Matteo Di Biase; Ingo Eitel; Francesco Santoro
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

2.  Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy.

Authors:  Thomas Klag; Giulio Cantara; Peter Ong; Martin Kaufmann; Udo Sechtem; Anastasios Athanasiadis
Journal:  Clin Res Cardiol       Date:  2013-11-26       Impact factor: 5.460

3.  Chemotherapy induced Takotsubo cardiomyopathy.

Authors:  Sunny Goel; Abhishek Sharma; Aakash Garg; Abhinav Chandra; Vijay Shetty
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 4.  Cancer as a Risk Factor for Cardiovascular Disease.

Authors:  Dana Elena Giza; Gloria Iliescu; Saamir Hassan; Konstantinos Marmagkiolis; Cezar Iliescu
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

Review 5.  Ischemic Heart Disease: Special Considerations in Cardio-Oncology.

Authors:  Dana Elena Giza; Fernando Boccalandro; Juan Lopez-Mattei; Gloria Iliescu; Kaveh Karimzad; Peter Kim; Cezar Iliescu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

6.  [Myocardial ischemia caused by overuse of headache medications].

Authors:  T Kraya; A Schlitt
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-02       Impact factor: 0.840

Review 7.  Cardiovascular complications of metastatic colorectal cancer treatment.

Authors:  Kalliopi Keramida; Georgios Charalampopoulos; Dimitrios Filippiadis; Elias Tsougos; Dimitrios Farmakis
Journal:  J Gastrointest Oncol       Date:  2019-08

8.  A case of ventricular fibrillation as a consequence of capecitabine-induced secondary QT prolongation: A case report.

Authors:  Kazuto Hayasaka; Masateru Takigawa; Atsushi Takahashi; Taishi Kuwahara; Kenji Okubo; Yasuaki Tanaka; Toru Misawa; Masafumi Mizusawa; Yosuke Yamakami; Keisuke Kojima; Yuichiro Sagawa; Keiichi Hishikari; Kazuya Yamao; Emiko Nakashima; Jun Nakajima; Shigeki Kimura; Katsumasa Takagi; Hiroyuki Hikita; Mitsuaki Isobe
Journal:  J Cardiol Cases       Date:  2017-04-29

Review 9.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

Review 10.  Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management.

Authors:  Michael E Layoun; Chanaka D Wickramasinghe; Maria V Peralta; Eric H Yang
Journal:  Curr Oncol Rep       Date:  2016-06       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.